Skip to content
BHCBausch Health Companies Inc.

Earnings

When Bausch Health Companies Inc. reports, what it reported each quarter, and how the stock took the results.

69 quarters. Jun 30, 2009 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Feb 17, after the close

Wed, Feb 17, 2027in 92 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Feb 16 – 26

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$2.80B
Revenue, change from a year earlier: Q3 2026 +9.7%, Q2 2026 +12.7%, Q1 2026 +11.7%, Q4 2025 +9.3%
Net income
-$112.00M
Net income, change from a year earlier: Q3 2026 +143.6%, Q2 2026 +74.3%, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 +139.6%, Q2 2026 +70.0%, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026$2.94B+9.7% vs Q3 2025

Latest results

  1. Q3 2026Oct 28, 2026, after the closeThe release+28.8%by the close of Oct 29
    Revenue
    $2.94B
    +9.7%
    Net income
    $436.00M
    +143.6%
    EPS
    $1.15
    +139.6%
    Read · nothing to show
  2. Q2 2026Jul 29, 2026, after the closeThe release+28.7%by the close of Jul 30
    Revenue
    $2.85B
    +12.7%
    Net income
    $258.00M
    +74.3%
    EPS
    $0.68
    +70.0%
  3. Q1 2026Apr 29, 2026, after the closeThe release+2.3%by the close of Apr 30
    Revenue
    $2.52B
    +11.7%
    Net income
    -$1.42B
    N/M
    EPS
    -$3.82
    N/M
  4. Q4 2025Feb 18, 2026, after the closeThe release4.2%by the close of Feb 19
    Revenue
    $2.80B
    +9.3%
    Net income
    -$112.00M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Oct 28, 2026 · after-hoursOct 29, 202629 d10-Q$2.94B+9.7%$1.15+28.8%
Q2 2026Jun 30, 2026Jul 29, 2026 · after-hoursJul 30, 202630 d10-Q$2.85B+12.7%$0.68+28.7%
Q1 2026Mar 31, 2026Apr 29, 2026 · after-hoursApr 30, 202630 d10-Q$2.52B+11.7%-$3.82+2.3%
FY 2025
Q4 2025derivedDec 31, 2025Feb 18, 2026 · after-hoursFeb 19, 202650 d10-K$2.80B+9.3%—4.2%
Q3 2025Sep 30, 2025Oct 29, 2025 · after-hoursOct 30, 202530 d10-Q$2.68B+6.8%$0.48+12.0%
Q2 2025Jun 30, 2025Jul 30, 2025 · after-hoursJul 31, 202531 d10-Q$2.53B+5.3%$0.407.8%
Q1 2025Mar 31, 2025Apr 30, 2025 · after-hoursMay 1, 202531 d10-Q$2.26B+4.9%-$0.160.0%
FY 2024
Q4 2024derivedDec 31, 2024Feb 19, 2025 · after-hoursFeb 20, 202551 d10-K$2.56B+6.3%—+10.3%
Q3 2024Sep 30, 2024Oct 30, 2024 · after-hoursOct 31, 202431 d10-Q$2.51B+12.2%-$0.23+12.6%
Q2 2024Jun 30, 2024Jul 31, 2024 · after-hoursAug 1, 202432 d10-Q$2.40B+10.9%$0.03+1.2%
Q1 2024Mar 31, 2024May 1, 2024 · after-hoursMay 2, 202432 d10-Q$2.15B+10.8%-$0.177.6%
Earlier years, FY 2009 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QOct 29, 2026000123
10-QJul 30, 2026000107
10-QApr 30, 2026000053
10-KFeb 19, 2026000023
10-QOct 30, 2025000051
10-QJul 31, 2025000032
10-QMay 1, 2025000020
10-KFeb 20, 2025000007
10-QOct 31, 2024000036
10-QAug 1, 2024000029

Provenance

ProvenanceData status and checks

Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR